Filter
Period
Filter by
recent search
Showing: 1 – 05 of 152 Regulated Information
–
23 October 2023
23 October 2023
Ipsen updates on E.U. Marketing Authorisation Application for odevixibat in Alagille syndrome
PARIS, FRANCE, 23 October 2023 – Ipsen (Euronext: IPN: ADR: IPSEY) today announced that the European Medicines Agency’s (EMA) Committee for Orphan Medicinal Products (COMP) confirmed its negative opinion recommending not to maintain the orphan designation for Bylvay® (odevixibat) in…
–
17 October 2023
17 October 2023
IPSEN – Buy-back programme – Art 5 of MAR – Week 41 – 2023
Aggregated presentation by day and by market
–
10 October 2023
10 October 2023
IPSEN – Buy-back programme – Art 5 of MAR – Week 40 – 2023
Aggregated presentation by day and by market
–
19 September 2023
19 September 2023
IPSEN – Buy-back programme – Art 5 of MAR – Week 37 – 2023
Aggregated presentation by day and by market
–
12 September 2023
12 September 2023
IPSEN – Buy-back programme – Art 5 of MAR – Week 36 – 2023
Aggregated presentation by day and by market